Document 0143 DOCN M95A0143 TI The management of sinusitis in patients infected with the human immunodeficiency virus (HIV). DT 9510 AU Tami TA; Department of Otolaryngology-Head and Neck Surgery, University of; Cincinnati, Ohio, USA. SO Ear Nose Throat J. 1995 May;74(5):360-3. Unique Identifier : AIDSLINE MED/95317220 AB As the Human Immunodeficiency Virus (HIV) has extended its influence across the United States, otolaryngologists have been increasingly called upon to manage its various head and neck manifestations. Sinusitis is a very prevalent, yet difficult, management problem in this patient population. The pathophysiology of sinusitis in this setting relates to altered helper T-lymphocyte function, an abnormal inflammatory response as well as increased IgE-mediated inflammation. Chronic HIV-related sinusitis is often due to Pseudomonas aeruginosa, Staphylococcus aureus, or anaerobic bacteria, and empiric antibiotic therapy must include these potential pathogens. Early cultures can facilitate organism-specific antibiotic therapy. Aggressive treatment with decongestants, topical nasal steroids, mucoevacuants and occasionally antihistamines should be included at maximal tolerated doses. When medical therapy fails, surgical drainage can be a safe and effective management option. Appropriately directed medical, and occasionally surgical, therapy can lead to a dramatic clinical response and provide an improved quality of life in this patient population. DE Antigens, CD AIDS-Related Opportunistic Infections/COMPLICATIONS Disease Transmission, Patient-to-Professional Drainage Drug Therapy Human HIV Seropositivity/*COMPLICATIONS Sinusitis/DRUG THERAPY/*ETIOLOGY/SURGERY T-Lymphocytes JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).